Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kendra N. Avery
Observed names:
K.N. Avery,
Kendra Avery,
Kendra N Avery
Institution:
Xencor (United States)
Observed institutions:
City Of Hope National Medical Center,
Pennsylvania State University,
City of Hope,
Xencor (United States),
Beckman Research Institute
ORCID:
0009-0008-9214-6395
Observed ORCID:
0009-0008-9214-6395
OpenAlex ID:
A5083837537
Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
2015
·
Can Küçük
, Bei Jiang
, et al.
·
Nature Communications
·
400
PDF
M13 Bacteriophage as a Biological Scaffold for Magnetically-Recoverable Metal Nanowire Catalysts: Combining Specific and Nonspecific Interactions To Design Multifunctional Nanocomposites
2009
·
Kendra N. Avery
, Janell E. Schaak
, et al.
·
Chemistry of Materials
·
64
Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies
2013
·
Joshua M. Donaldson
, Cindy Zer
, et al.
·
Proceedings of the National Academy of Sciences
·
53
PDF
A Platform To Enhance Quantitative Single Molecule Localization Microscopy
2018
·
Ottavia Golfetto
, Devin L. Wakefield
, et al.
·
Journal of the American Chemical Society
·
36
A B7-H3–Targeted CD28 Bispecific Antibody Enhances the Activity of Anti–PD-1 and CD3 T-cell Engager Immunotherapies
2024
·
Gregory L. Moore
, Veronica G. Zeng
, et al.
·
Molecular Cancer Therapeutics
·
20
PDF
Abstract 2962: ASP2138, a novel 2+1 format, claudin 18.2 x CD3 bispecific antibody, demonstrates selectivity and activity in preclinical cancer models
2023
·
Taisuke Nakazawa
, Hiroaki Tanaka
, et al.
·
Cancer Research
·
17
Mechanically interlocked functionalization of monoclonal antibodies
2018
·
Krzysztof P. Bzymek
, James W. Puckett
, et al.
·
Nature Communications
·
14
PDF
Abstract 5565: Potency-reduced IL15/IL15Rα heterodimeric Fc-fusions display enhanced in vivo activity through increased exposure
2018
·
Matthew J. Bernett
, Rajat Varma
, et al.
·
Cancer Research
·
13
IL-15/IL-15Rα-Fc-Fusion Protein XmAb24306 Potentiates Activity of CD3 Bispecific Antibodies through Enhancing T-Cell Expansion
2024
·
Ji Li
, Robyn Clark
, et al.
·
Molecular Cancer Therapeutics
·
12
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one
2016
·
Andreas Lundqvist
, Vincent van Hoef
, et al.
·
Journal for ImmunoTherapy of Cancer
·
12
PDF
Abstract 2784: Simultaneous checkpoint-checkpoint or checkpoint-costimulatory receptor targeting with bispecific antibodies promotes enhanced human T cell activation
2018
·
Michael Hedvat
, Christine Bonzon
, et al.
·
Cancer Research
·
10
Engineering a high-affinity peptide binding site into the anti-CEA mAb M5A
2017
·
Cindy Zer
, Kendra N. Avery
, et al.
·
Protein Engineering Design and Selection
·
9
PDF
Development of a High Affinity, Non-covalent Biologic to Add Functionality to Fabs
2015
·
Kendra N. Avery
, Cindy Zer
, et al.
·
Scientific Reports
·
9
PDF
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapy
2024
·
Rajbharan Yadav
, Suzanne Schubbert
, et al.
·
Frontiers in Pharmacology
·
8
Abstract 1860: Bispecific claudin-6 x CD3 antibodies in a 2 + 1 format demonstrate selectivity and activity on human ovarian cancer cells
2021
·
Matthew S. Faber
, Sung-Hyung Lee
, et al.
·
Cancer Research
·
8
Using quantitative single molecule localization microscopy to optimize multivalent HER2-targeting ligands
2023
·
Devin L. Wakefield
, Ottavia Golfetto
, et al.
·
Frontiers in Medicine
·
7
PDF
Abstract 2286: XmAb30819, an XmAb®2+1 ENPP3 x CD3 bispecific antibody for RCC, demonstrates safety and efficacy in in vivo preclinical studies
2020
·
Alex Nisthal
, Sung-Hyung Lee
, et al.
·
Cancer Research
·
6
Abstract 2080: LAG3-targeted IL15/IL15Rα-Fc (LAG3 x IL15) fusion proteins for preferential TIL expansion
2022
·
Matthew J. Bernett
, Suzanne Schubbert
, et al.
·
Cancer Research
·
5
1372 XmAb143, an engineered IL18 heterodimeric Fc-fusion, features improved stability, reduced potency, and insensitivity to IL18BP
2022
·
Alex Nisthal
, Sung-Hyung Lee
, et al.
·
Journal for ImmunoTherapy of Cancer
·
3
PDF
Regulatory T Cell Selective IL-2-Fc Fusion Proteins for the Treatment of Autoimmune Diseases
2018
·
Rajat Varma
, Ke Liu
, et al.
·
Blood
·
3
Meditope–Fab interaction: threading the hole
2017
·
Krzysztof P. Bzymek
, Yuelong Ma
, et al.
·
Acta Crystallographica Section F Structural Biology Communications
·
3
PDF
1067 Synergistic combination of natural killer cell engagers (NKEs) with proinflammatory cytokines
2022
·
Tian Zhang
, Matthew Faber
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
697 Tumor-targeted CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors
2020
·
Michael Hedvat
, Veronica Zeng
, et al.
·
Journal for ImmunoTherapy of Cancer
·
2
PDF
Tu1468 DISCOVERY AND CHARACTERIZATION OF XMAB412: A NOVEL, HIGH-AFFINITY, ANTI-TL1A X ANTI-IL23 NATIVE-LIKE BISPECIFIC ANTIBODY WITH EXTENDED HALF-LIFE FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
2026
·
Matthew S. Faber
, Kendra N. Avery
, et al.
·
Gastroenterology
·
1
Abstract 2983: Tumor-specific CD28 costimulatory bispecific antibodies enhance T cell activation in solid tumors
2023
·
Matthew A. Dragovich
, Viralkumar Davra
, et al.
·
Cancer Research
·
1
Show more works
View as search
Works count:
77
Citation count:
736
H-index:
11
I10-index:
12
Year
Topic
Type
